Anthrax vaccines

Anthrax vaccines

<b>SUMMARY</b> : Anthrax, an uncommon disease in humans, is caused by a large bacterium, <i> Bacillus anthracis. </i> The risk of inhalation infection is the main indication for anthrax vaccination. Pre-exposure vaccination is provided by an acellular vaccine (anthrax vaccine...

Full description

Bibliographic Details
Main Authors:	Splino Miroslav, Patocka Jiri, Prymula Roman, Chlibek Roman
Format:	Article
Language:	English
Published:	King Faisal Specialist Hospital and Research Centre 2005-01-01
Series:	Annals of Saudi Medicine
Online Access:	http://www.saudiannals.net/article.asp?issn=0256-4947;year=2005;volume=25;issue=2;spage=143;epage=149;aulast=Splino

Similar Items

Prophylaxis Against Anthrax
by: Miroslav Špliňo, et al.
Published: (2002-01-01)

Anthrax Toxin Characterization
by: Jiří Patočka, et al.
Published: (2002-01-01)

Botulism and Bioterrorism: How Serious is This Problem?
by: Jiří Patočka, et al.
Published: (2005-01-01)

Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children
by: Prymula Roman, et al.
Published: (2010-06-01)

Anthrax vaccine–induced nodules
by: Jessica May Franklin, BS, et al.
Published: (2020-09-01)

Absence of Mycoplasma Contamination in the Anthrax Vaccine
by: Mary Kate Hart, et al.
Published: (2002-01-01)

HEPA/Vaccine Plan for Indoor Anthrax Remediation
by: Lawrence M. Wein, et al.
Published: (2005-01-01)

The Control of Anthrax Disease: Diagnosis, Vaccination and Investigation
by: Rahmat Setya Adji, et al.
Published: (2006-12-01)

The Role of Russian Scientists in the Development of Anthrax Vaccines
by: M.V. Supotnytskyi, et al.
Published: (2015-09-01)

Civil-military relations and the anthrax vaccine debate
by: Martel, Christine
Published: (2018)

The role of Russian and Soviet scientists in the development of anthrax vaccines
by: M. V. Supotnitskiy, et al.
Published: (2018-02-01)

Insufficient Anthrax Lethal Toxin Neutralization Is Associated with Antibody Subclass and Domain Specificity in the Plasma of Anthrax-Vaccinated Individuals
by: Kenneth Smith, et al.
Published: (2021-06-01)

A Comparison of the Adaptive Immune Response between Recovered Anthrax Patients and Individuals Receiving Three Different Anthrax Vaccines.
by: Thomas R Laws, et al.
Published: (2016-01-01)

Maximization of Livestock Anthrax Vaccination Coverage in Bangladesh: An Alternative Approach
by: M. Shahjahan A. Sarker, et al.
Published: (2020-08-01)

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine.
by: Darly J Manayani, et al.
Published: (2007-10-01)

Biophysical characterization of affinity maturation in the human response to anthrax vaccine
by: Ataca, Sila
Published: (2018)

LICENSED ANTHRAX VACCINES AND EXPERIMENTAL PREPARATIONS AT THE STAGE OF CLINICAL TRIALS
by: N. I. Mikshis, et al.
Published: (2017-08-01)

Studying the efficacy of giving anthrax toxin as a vaccine intranasally and subcutaneously
by: Al-Zubaidy I.A. H.
Published: (2008-12-01)

COMPLIANCE OF ANTHRAX RECOMBINANT VACCINE PROTOTYPE WITH THE REQUIREMENTS TO IMMUNE-BIOLOGICAL PREPARATIONS
by: N. I. Mikshis, et al.
Published: (2018-11-01)

Examination of the immunoglobulin repertoire before and after Anthrax Vaccine Adsorbed immunization
by: Sawatzki, Kaitlin Michele Robbins
Published: (2018)

Cutaneous Anthrax
by: Sheikh Muhammad Nazir
Published: (2004-06-01)

The Anthrax Outbreak
by: MA Jalil Chowdhury, et al.
Published: (2011-02-01)

Giant anthrax
by: Ana Isel Polo-Soto, et al.
Published: (2021-02-01)

A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague
by: Pan Tao, et al.
Published: (2018-10-01)

Current State of Anthrax Vaccines and Key R&D Gaps Moving Forward
by: Adam Clark, et al.
Published: (2020-04-01)

Reindeer Anthrax in the Russian Arctic, 2016: Climatic Determinants of the Outbreak and Vaccination Effectiveness
by: Elena A. Liskova, et al.
Published: (2021-06-01)

PERSPECTIVES OF DEVELOPMENT OF LIVE RECOMBINANT ANTHRAX VACCINES BASED ON OPPORTUNISTIC AND APATHOGENIC MICROORGANISMS
by: P. Yu. Popova, et al.
Published: (2016-02-01)

Theoretical and Experimental Substantiation of Alternative Methods for Quality Control of Live Anthrax Vaccine
by: I. V. Kasina, et al.
Published: (2020-12-01)

The F-34 Stern strain Anthrax vaccine induced higher level of anti-anthrax IgG antibody response and appeared protective in mice model
by: Provat Chandra Saha, et al.
Published: (2020-06-01)

An Outbreak Of Human Anthrax : A Report Of 15 Cases Of Cutaneous Anthrax
by: Thappa Devinder Mohan, et al.
Published: (2000-01-01)

Genomic copy number variants: evidence for association with antibody response to anthrax vaccine adsorbed.
by: Michael I Falola, et al.
Published: (2013-01-01)

Modeling the environmental suitability of anthrax in Ghana and estimating populations at risk: Implications for vaccination and control.
by: Ian T Kracalik, et al.
Published: (2017-10-01)

Protective antigen domain 4 of Bacillus anthracis as a candidate for use as vaccine for anthrax
by: Dorota Żakowska, et al.
Published: (2019-09-01)

Anthrax of the Gastrointestinal Tract
by: Thira Sirisanthana, et al.
Published: (2002-07-01)

Anthrax, but not Bacillus anthracis?
by: Richard Okinaka, et al.
Published: (2006-11-01)

Neurologic Complications of Anthrax
by: J Gordon Millichap
Published: (2003-06-01)

Anthrax vaccine as a component of the strategic national stockpile: a dilemma for Homeland Security
by: Rempfer, Thomas L.
Published: (2012)

Detecting specific memory t and b cells in volunteers annually revaccinated with live anthrax vaccine
by: V. V. Firstova, et al.
Published: (2019-11-01)

Development of Brucella abortus RB51 as a Vaccine to Protect Against Brucellosis and Anthrax
by: Poff-Reichow, Sherry Ann
Published: (2011)

Anthrax in the Territory of Dagestan
by: A. N. Kulichenko, et al.
Published: (2013-06-01)